Skip to main content
Caplight Logo









Bened Biomedical Co., Ltd.

Bened Biomedical Co., Ltd.

Private
TaipeiHealthcare & Life Scienceshttps://www.benedbiomed.com/

Last Round

Series A

May 23, 2022

Total Funding Raised

$10M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Bened Biomedical Co., Ltd. is a biotechnology company that researches, develops, and manufactures medical probiotics, known as psychobiotics, designed to address neuropsychological, allergic, immunological, and metabolic disorders through the gut-brain axis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Mental Health, Clinical Trials, D2C Brands, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

psychobioticsgut-brain axisprobioticsmental health supplementsneurological healthODM servicesoriginal design manufacturernutritional supplementsnutraceuticalsprobiotic strainsingredient licensingPS128private label supplementsD2C supplementsmicrobiomeautism supportparkinson's supportmedical foodsleep aidpet probiotics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bened Biomedical Co., Ltd. Comparables

Compare Bened Biomedical Co., Ltd. with similar companies based on industry and business-model similarity.

Bened Biomedical Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Verb Biotics
79%
Kaneka Corporation
76%
Novonesis
74%

Bened Biomedical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 23, 2022

Key People

Founding team and executive leadership

Allen King

Chief Financial Officer

Executive Team

Bened Biomedical Co., Ltd. Investors

Notable investors and investment history

Bened Biomedical Co., Ltd. investors
InvestorRounds
Trans-Pacific Technology FundSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 61% MoM, reaching 3.6K.

  • Jan 27, 2026

    Monthly visitors increased 94% MoM.

Bened Biomedical Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bened Biomedical Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bened Biomedical Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTaipei
Employee Range20
Year Founded2015
Last FundingMay 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?